Related references
Note: Only part of the references are listed.High-throughput dynamic BH3 profiling may quickly and accurately predict effective therapies in solid tumors
Patrick D. Bhola et al.
SCIENCE SIGNALING (2020)
Nivolumab plus Ipilimumab in Advanced Non-Small-Cell Lung Cancer
M. D. Hellmann et al.
NEW ENGLAND JOURNAL OF MEDICINE (2019)
A selective BCL-XL PROTAC degrader achieves safe and potent antitumor activity
Sajid Khan et al.
NATURE MEDICINE (2019)
ER Stress Signaling Promotes the Survival of Cancer Persister Cells Tolerant to EGFR Tyrosine Kinase Inhibitors
Hideki Terai et al.
CANCER RESEARCH (2018)
Patient-derived xenografts undergo mouse-specific tumor evolution
Uri Ben-David et al.
NATURE GENETICS (2017)
Combination Cancer Therapy Can Confer Benefit via Patient-to-Patient Variability without Drug Additivity or Synergy
Adam C. Palmer et al.
CELL (2017)
iBH3: simple, fixable BH3 profiling to determine apoptotic priming in primary tissue by flow cytometry
Jeremy Ryan et al.
BIOLOGICAL CHEMISTRY (2016)
Cancer treatment and survivorship statistics, 2016
Kimberly D. Miller et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2016)
Targeted Therapy and Immunotherapy for Lung Cancer
Evan C. Naylor et al.
SURGICAL ONCOLOGY CLINICS OF NORTH AMERICA (2016)
Drug-Induced Death Signaling Strategy Rapidly Predicts Cancer Response to Chemotherapy
Joan Montero et al.
CELL (2015)
Relative Mitochondrial Priming of Myeloblasts and Normal HSCs Determines Chemotherapeutic Success in AML
Thanh-Trang Vo et al.
CELL (2012)
High-Throughput Detection of Actionable Genomic Alterations in Clinical Tumor Samples by Targeted, Massively Parallel Sequencing
Nikhil Wagle et al.
CANCER DISCOVERY (2012)
Pretreatment Mitochondrial Priming Correlates with Clinical Response to Cytotoxic Chemotherapy
Triona Ni Chonghaile et al.
SCIENCE (2011)
The BCL-2 Family Reunion
Jerry E. Chipuk et al.
MOLECULAR CELL (2010)
A Primary Xenograft Model of Small-Cell Lung Cancer Reveals Irreversible Changes in Gene Expression Imposed by Culture In vitro
Vincent C. Daniel et al.
CANCER RESEARCH (2009)
The BCL-2 protein family: opposing activities that mediate cell death
Richard J. Youle et al.
NATURE REVIEWS MOLECULAR CELL BIOLOGY (2008)
Expression and purification of recombinant annexin V for the detection of membrane alterations on apoptotic cells
Gabriela Brumatti et al.
METHODS (2008)
BH3 profiling identifies three distinct classes of apoptotic blocks to predict response to ABT-737 and conventional chemotherapeutic agents
Jing Deng et al.
CANCER CELL (2007)
Mitochondria primed by death signals determine cellular addiction to antiapoptotic BCL-2 family members
Michael Certo et al.
CANCER CELL (2006)
BH3 domains of BH3-only proteins differentially regulate bax-mediated mitochondrial membrane permeabilization both directly and indirectly
T Kuwana et al.
MOLECULAR CELL (2005)
If phosphatidylserine is the death knell, a new phosphatidylserine-specific receptor is the bellringer
VA Fadok et al.
CELL DEATH AND DIFFERENTIATION (2001)
A receptor for phosphatidylserine-specific clearance of apoptotic cells
VA Fadok et al.
NATURE (2000)
Share Paper
